(Q41788304)

English

Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma

scientific article published on 12 May 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma (English)

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

1 reference

based on heuristic

inferred from title

author name string

Akihiko Ohwada

1

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Kei Inami

2

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Emi Onuma

3

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Mariko Matsumoto-Yamazaki

4

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Ryo Atsuta

5

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Kazuhisa Takahashi

6

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

publication date

12 May 2011

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Experimental and Therapeutic Medicine

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

2

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

619-623

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

6 June 2018

Interpretative strategies for lung function tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

6 June 2018

Standardisation of spirometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

6 June 2018

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

6 June 2018

Retrospective characterization of airway reversibility in patients with asthma responsive to bronchodilators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

18 August 2018

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

18 August 2018

Peripheral inflammation in patients with asthmatic symptoms but normal lung function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

18 August 2018

Asthma Mortality and Long-Acting Beta2-Agonists in Five Major European Countries, 1994–2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440754

2 December 2018

Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The FDA and safe use of long-acting beta-agonists in the treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22977550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/ETM.2011.268

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41788304&oldid=1927909534"